JD HEALTH
06618
BIDU-SW
09888
ALI HEALTH
00241
JD-SW
09618
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 85.04%-1.66M | -89.06%18.35M | -109.79%-11.08M | -35.65%167.71M | -15.05%113.14M | 1,426.87%260.61M | 210.27%133.19M | -75.87%17.07M | -801.92%-120.79M | -48.73%70.73M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -131.15%-17.79M | -76.04%-35.3M | 45.04%-7.69M | 5.21%-20.05M | -70.72%-14M | -146.72%-21.15M | -112.82%-8.2M | 8.85%-8.57M | 5.26%-3.85M | -63.91%-9.41M |
Investment loss (gain) | ---- | 46.84%42.02M | ---- | --28.62M | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | 2,424.10%1.93M | -489.18%-2.05M | -103.84%-83K | 126.39%527K | 242.80%2.16M | 29.58%-2M | -120.19%-1.51M | -201.70%-2.84M | 231.88%7.5M | -113.31%-940K |
-Impairment of property, plant and equipment (reversal) | ---- | --267K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | 1,311.36%1.86M | -440.49%-1.79M | -93.43%132K | 129.73%526K | 235.99%2.01M | 34.99%-1.77M | -119.24%-1.48M | -263.92%-2.72M | 286.98%7.68M | -68.11%1.66M |
-Impairment of trade receivables (reversal) | 137.50%78K | -43,600.00%-435K | -236.84%-208K | 100.91%1K | 141.27%152K | 4.35%-110K | 134.43%63K | 95.58%-115K | 88.40%-183K | -240.09%-2.6M |
-Other impairments and provisions | -71.43%-12K | ---92K | ---7K | ---- | ---- | ---118K | ---99K | ---- | ---- | ---- |
Revaluation surplus: | -97.56%230K | ---- | 921.90%9.42M | ---- | -402.37%-1.15M | ---- | 49.80%379K | ---- | -74.21%253K | ---- |
-Other fair value changes | -97.56%230K | ---- | 921.90%9.42M | ---- | -402.37%-1.15M | ---- | 49.80%379K | ---- | -74.21%253K | ---- |
Asset sale loss (gain): | --1.02M | 3,803.41%3.26M | ---- | 99.15%-88K | ---- | -1,167.60%-10.31M | ---10.8M | --966K | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---10.82M | ---10.82M | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | --1.02M | 3,803.41%3.26M | ---- | -117.29%-88K | ---- | -47.31%509K | --23K | --966K | ---- | ---- |
Depreciation and amortization: | -13.10%46.08M | 5.04%84.84M | 52.78%53.03M | -46.89%80.77M | -67.54%34.71M | -17.89%152.07M | 34.28%106.93M | 39.22%185.21M | 24.01%79.63M | 81.46%133.04M |
-Depreciation | ---- | 16.93%74.66M | ---- | -52.96%63.85M | ---- | -19.78%135.74M | ---- | 39.97%169.22M | ---- | 67.88%120.89M |
-Amortization of intangible assets | 5.43%1.32M | 61.40%4.57M | 26.98%1.25M | 34.27%2.83M | -13.36%986K | 0.81%2.11M | 21.58%1.14M | 25.15%2.09M | 26.32%936K | 28.36%1.67M |
Financial expense | -91.39%51K | -60.45%651K | -35.09%592K | -37.34%1.65M | -40.66%912K | -64.50%2.63M | -73.70%1.54M | -77.98%7.4M | -78.62%5.85M | 85.67%33.61M |
Exchange Loss (gain) | 103.17%137K | -33.29%-22.65M | -1,014.62%-4.32M | -1,308.46%-16.99M | --472K | -73.69%1.41M | ---- | 5.07%5.34M | ---- | 86.51%5.09M |
Special items | ---- | ---- | ---- | 90.00%-72K | ---- | -718.18%-720K | ---14K | 73.25%-88K | ---- | -122.05%-329K |
Operating profit before the change of operating capital | -24.73%30.01M | -63.18%89.12M | -70.74%39.87M | -36.72%242.07M | -38.49%136.25M | 87.06%382.53M | 805.22%221.51M | -11.78%204.5M | -131.48%-31.41M | -3.51%231.79M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -168.87%-6.68M | -123.57%-63.72M | -95.33%9.7M | 40.39%270.4M | -28.83%207.67M | 151.18%192.61M | 208.35%291.77M | -209.56%-376.34M | -53.54%94.62M | 196.72%343.49M |
Accounts receivable (increase)decrease | 17.58%-137.68M | 98.45%188.88M | -180.52%-167.04M | 72.58%95.18M | 76.90%-59.55M | -93.51%55.15M | -125.63%-257.77M | 197.26%849.53M | 258.89%1.01B | 127.62%285.79M |
Accounts payable increase (decrease) | 1,427.05%346.81M | 92.98%-31.54M | 89.53%-26.13M | -3,406.62%-449.54M | -304.10%-249.72M | -97.99%13.6M | 136.15%122.35M | 156.81%678M | 174.95%51.81M | -195.74%-1.19B |
prepayments (increase)decrease | 13,922.30%42.16M | -716.33%-76.79M | 98.37%-305K | 844.27%12.46M | -162.36%-18.69M | -116.05%-1.67M | 10.93%29.97M | -71.19%10.43M | 287.56%27.02M | 193.53%36.21M |
Derivative financial instruments (increase) decrease | 102.42%229K | 213.82%11.56M | 15.07%-9.48M | -982.62%-10.16M | -1,154.44%-11.16M | 799.22%1.15M | 440.19%1.06M | 196.24%128K | ---311K | -411.54%-133K |
Special items for working capital changes | -7.43%7.05M | -81.14%-2.77M | 40.23%7.62M | 59.09%-1.53M | 384.65%5.43M | -127.95%-3.73M | -118.77%-1.91M | 339.57%13.35M | 1,919.32%10.17M | -56.27%3.04M |
Cash from business operations | 293.39%281.9M | -27.78%114.75M | -1,522.68%-145.77M | -75.16%158.88M | -97.48%10.25M | -53.64%639.63M | -64.84%406.99M | 570.28%1.38B | 379.90%1.16B | -548.82%-293.36M |
Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | 93.05%-128K | ---- | ---1.84M | ---- |
China income tax paid | -476.47%-9.19M | 41.12%-17.31M | 79.31%-1.59M | 25.36%-29.39M | 46.01%-7.7M | -89.96%-39.38M | 1.08%-14.27M | 38.95%-20.73M | 52.16%-14.43M | -28.48%-33.95M |
Net cash from operations | 285.06%272.71M | -24.75%97.44M | -5,897.09%-147.36M | -78.43%129.49M | -99.35%2.54M | -55.83%600.26M | -65.60%392.59M | 515.16%1.36B | 357.21%1.14B | -940.67%-327.31M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 131.15%17.79M | 76.04%35.3M | -45.04%7.69M | -5.21%20.05M | 70.72%14M | 146.72%21.15M | 112.82%8.2M | -8.85%8.57M | -5.26%3.85M | 63.91%9.41M |
Loan receivable (increase) decrease | ---- | 200.00%693.25M | --693.25M | ---693.25M | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---229.72M | ---846.4M | ---- | ---- | ---- | ---19M | ---40M | ---- | ---- | ---- |
Sale of fixed assets | 111.93%288K | 322.51%3.57M | -3,235.06%-2.41M | -45.12%844K | -95.89%77K | 8.01%1.54M | 395.24%1.87M | --1.42M | --378K | ---- |
Purchase of fixed assets | 38.41%-54.51M | 10.93%-151.15M | -11.07%-88.5M | 28.96%-169.7M | 38.74%-79.68M | -14.80%-238.89M | 23.98%-130.07M | 47.60%-208.1M | -131.64%-171.1M | -103.00%-397.12M |
Purchase of intangible assets | ---- | 34.07%-803K | ---- | -49.26%-1.22M | ---- | 69.51%-816K | -407.69%-396K | 91.65%-2.68M | 99.74%-78K | -2,243.79%-32.06M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --282.81M | --82.61M | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---50.13M | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | -787.77%-42.02M | ---- | --6.11M | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -143.63%-266.16M | 65.26%-308.27M | 1,029.86%610.02M | -1,996.29%-887.29M | 15.66%-65.6M | 123.31%46.79M | 53.41%-77.79M | 52.17%-200.78M | -66.93%-166.95M | -120.33%-419.77M |
Net cash before financing | -98.58%6.56M | 72.18%-210.83M | 833.66%462.66M | -217.12%-757.8M | -120.03%-63.06M | -44.13%647.05M | -67.69%314.8M | 255.02%1.16B | 279.19%974.28M | -392.85%-747.09M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -94.76%3.16M | ---- | -17.62%60.32M | -44.63%67M | -62.31%73.22M | -51.20%121M | -82.51%194.29M | -81.85%247.96M | 115.46%1.11B |
Refund | 94.69%-3.16M | 18.24%-62.32M | -9.78%-59.51M | -74.06%-76.22M | -10,741.40%-54.21M | 95.66%-43.79M | 99.95%-500K | -117.95%-1.01B | -144.46%-1.01B | 15.03%-462.68M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --117K | ---- | ---- | ---- | 912.34%17.39M |
Interest paid - financing | ---- | 60.53%-652K | -39.08%-1.03M | 89.67%-1.65M | 95.01%-737K | -111.98%-15.99M | -165.84%-14.76M | 76.95%-7.55M | 79.55%-5.55M | -115.33%-32.74M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---8.42M | ---8.42M | ---- | ---- | ---52.8M |
Net cash from financing operations | 94.78%-3.16M | -93.39%-64.58M | -1,564.27%-60.53M | -280.74%-33.39M | -95.42%4.13M | 98.95%-8.77M | 111.72%90.33M | -246.64%-835.63M | -182.14%-770.97M | 827.07%569.85M |
Effect of rate | 0.13%9.71M | 17.27%19.61M | -54.53%9.7M | 1,171.17%16.72M | 5,804.01%21.33M | 77.03%-1.56M | -1,396.00%-374K | -890.35%-6.8M | 97.94%-25K | 482.22%860K |
Net Cash | -99.16%3.4M | 65.19%-275.4M | 782.41%402.13M | -223.96%-791.19M | -114.55%-58.93M | 97.93%638.28M | 99.27%405.13M | 281.94%322.47M | -48.52%203.31M | 22.92%-177.24M |
Begining period cash | -91.69%23.18M | -73.52%278.97M | -73.52%278.97M | 152.79%1.05B | 152.79%1.05B | 312.38%416.73M | 312.38%416.73M | -63.58%101.05M | -63.58%101.05M | -45.35%277.44M |
Cash at the end | -94.75%36.29M | -91.69%23.18M | -32.00%690.8M | -73.52%278.97M | 23.66%1.02B | 152.79%1.05B | 169.93%821.49M | 312.38%416.73M | -54.65%304.34M | -63.58%101.05M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.